Additional Transaction Details Ovintiv will use cash and issue approximately 31.8 million shares of Ovintiv common stock in conjunction with the transaction, down from the original 32.6 million shares estimated at the transaction announcement date. Customary closing adjustments are expected to result in an upward adjustment of approximately $85 million associated with the Midland Basin acquisition and a $110 million reduction in Bakken sale proceeds. One-time transaction-related costs, including financing costs, bridge loan costs, fees, insurance costs and restructuring costs are expected to total approximately $80 to $85 million.